Business Wednesday, Apr 22
Everything you need to know as people taking Ramipril told ‘contact pharmacy’ – The Mirror

Need to know

The MHRA has recalled a batch of Ramipril high blood pressure medication

Need to know: Urgent recall for Ramipril high blood pressure medication

  • Patients taking Ramipril 10mg capsules are being urged to check their medication after a batch recall due to packaging errors.
  • The Medicines and Healthcare products Regulatory Agency (MHRA) announced that Crescent Pharma Limited is recalling one batch as a precautionary measure. The company received a complaint where “inside a sealed carton of Ramipril 10 mg Capsules Batch No.: GR174091, one blister pack of Ramipril 5 mg Capsules Batch No.: GR164094 was found.”
  • Healthcare professionals have been instructed to halt supply and quarantine stocks of the affected batch immediately.
  • Patients prescribed Ramipril 10mg who have batch number GR174091 should check their cartons contain the correct medication. The MHRA advises: “If the carton contains blister strips that are labelled and contain Ramipril 5 mg capsule, contact your dispensing pharmacy in the first instance.”
  • The regulator stressed that both strengths treat high blood pressure, heart failure and kidney disease. Any impact from receiving a lower dose would be gradual rather than immediate or life-threatening.
  • Those with concerns should seek medical advice and report any adverse reactions via the MHRA Yellow Card scheme.
  • READ THE FULL STORY: New urgent ‘contact pharmacy’ alert to people taking Ramipril
Follow mirror:

At Reach and across our entities we and our partners use information collected through cookies and other identifiers from your device to improve experience on our site, analyse how it is used and to show personalised advertising. You can opt out of the sale or sharing of your data, at any time clicking the “Do Not Sell or Share my Data” button at the bottom of the webpage. Please note that your preferences are browser specific. Use of our website and any of our services represents your acceptance of the use of cookies and consent to the practices described in our Privacy Notice and Terms and Conditions.

Share.
Exit mobile version